Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability

European Journal of Histochemistry

Volumn 44, Issue 2, 2000, Pages 143-156

  Khaled, A ^a   Imamura, Y ^a   Noriki, S ^a   Fukuda, M ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

AgNOR; Bcl 2; DNA instability; Human cervical dysplasia; Interphase cytogenetics; P53; PCNA

Indexed keywords

CYCLINE; DNA; PROTEIN BCL 2; PROTEIN P53; SILVER NITRATE;

ARTICLE; CARCINOMA IN SITU; DISEASE COURSE; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; INTERPHASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TIME; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERPHASE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; SILVER NITRATE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 0033860438     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Anderson M.C.: Premalignant and malignant squamous lesions of the cervix. In: Haines and Taylors Obstetrical and Gynaecological Pathology (Eds. Fox H. and Wells M.), Churchill Livingstone publication, New York, 273-322, 1994.
2. Arden K. C., Pathak. S., Frankel L.S., and Zander A.: AgNOR staining in human chromosomes: differential staining in normal and leukaemic bone marrow samples. Int. J. Cancer 36, 647-649, 1985.
3. Ayres J.G., Crocker J., and Skilbeck N.Q.: Differentiation of malignant from normal and reactive mesothelial cells using argyrophil technique for nucleolar organizer region associated proteins. Thorax 43, 366-370, 1988.
4. Bakhsi A., Jansen J. P., Goldman P., Wright J. J, Mcbride O.W., Epstein A.L., and Korsmeyer S.J.: Cloning the chromosomal breakpoint of t(14,18) human lymphoma: clustering around Jh on chromosome 14 near a transcriptional unit of chromosome 18. Cell 41, 899-906, 1985.
5. Burtek J., Iggo R., Gannon J., and Lane D.B.: Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5, 893-899, 1990.
6. Bosari S., Roncalli M., Viale G., Bossi P., and Coggi G.: p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J. Pathol. 169, 425-430, 1993.
7. Bravo R., and Frank R.: Cyclin /PCNA is the auxiliary protein of DNA polymerase delta. Nature 309, 515-520, 1987.
8. Bulten J., Poddighe P.J., Robben J.C.M., Gemmink J.H., Wilde P.C.M., and Hanselaar A.G.J.M.: Interphase cytogenetic analysis of cervical intraepithelial neoplasia. Am. J. Pathol. 152, 495-503, 1998.
9. Carmen C.W.Y., Christopher D.M., Paul L.N., John R.G., Julia C.B., and David A.L.: A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining and histological grading in gastrointestinal stromal tumour. J. Pathol. 166, 147-152, 1992.
10. Chi C.H., Rubio C.A., and Lagerlof B.: The frequency and distribution of mitotic figures in dysplasia and carcinoma in situ. Cancer 39, 1218-1223, 1977.
11. Cooper K., Haffajee Z., and Taylor L.: bcl-2 immunoreactivity, human papillomavirus DNA and cervical intraepithelial neoplasia. Mod. Palhol. 12, 612-617, 1999.
12. Crawford L. V., Pein D.C. and Lamb P.: The cellular protein p53 in human tumours. Mol. Bio. Med. 2, 261-272, 1984.
13. Crocker J., and Naro P.: Nucleolar organizer regions in lymphoma. J. Pathol. 151, 111-118, 1987.
14. Crook T., Wrede D., and Tidy J.A.: Clonal p53 mutation in primary cervical cancer: association with human-papilloma virus negative tumours. Lancet 339, 1070-1073, 1992.
15. Davidson B., Goldberg I., Kopolovic J., Lerner-Geva L., Gotlieb W.H., Weis B., Ben-Baruch G., and Reich R.: Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix. Clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynaecol. Oncol. 72, 380-386, 1999.
16. Dervan P.A., Gilmartin L.G., Loftus B.M., Carney D.N.: Breast carcinoma kinetics. Argyrophillic nucleolar organizer regions counts correlate with Ki-67 scores. Am. J. Clin. Pathol. 92, 401-407, 1989.
17. Finlay C.A., Hinds P.W., Tan T.H., Eliyahu D., Oren M., and Levine A.J.: Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-P53 complex with an altered half life. Mol. Cell Bio. 8, 531-539, 1988.
18. Fukuda M., Miyoshi N., Hattori T., Sugihara H., Hosokawa Y., and Nakanishi K.: Different instability of nuclear DNA at acid hydrolysis in cancerous and non cancerous cells as revealed by fluorescent staining with acridine orange. Histochem. 84, 556-560, 1986.
19. Fukuda M., Noriki S., Imamura Y., Miyoshi N., Kimura S., Koizumi K., Suzuki K., Sakurai H., and Sakaguchi R.: Differential immunohistochemical staining of cancerous cells with anti-single-stranded DNA antiserum in ordinary pathological paraffin section after DNA-denaturation by acid hydrolysis. Eur. J. Histochem. 37, 309-319, 1993.
20. Garzetti G.G., Ciavattini A., Denictolis M., Lucarini G., Goteri G., Romanini C., and Biagini G.: MIB-1 immunostaining in cervical intraepithelial neoplasia: Prognostic significance in mild and moderate lesions. Gynecol. Obstet. Invest. 42, 261-266, 1996.
21. Goodpasture C., and Bloom S.E.: Visualization of nuclear organizer regions in mammalian chromosomes using silver staining. Chromosoma 53, 37-50, 1975.
22. Graham D.A., Southern S.A., Mcdicken I.W., and Herrington C.S.: Interphase cytogenetic evidence for distinct genetic pathways in the development of squamous neoplasia of the uterine cervix. Lab. Invest. 78, 289-297, 1998.
23. Guo Z., Wilander E., Sallstrom J., and Ponten J.: Deletion of chromosome 3p is an early event in malignant progression of cervical cancer. Anticancer Res. 18, 707-712, 1998.
24. Helland A., Holm R., Kristensen G., Borrensen A.L., and Nesland J.M.: Genetic alteration of the TP53 gene p53 protein expression and HPV in primary cervical carcinoma. J. Pathol 171, 105-114, 1993.
25. Heselmeyer K., Schrock E., Manoir S.D., Blegan H., Shah K., Steinbeck R., Auer G., and Reid T.: Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl. Acad. Sci. USA 93, 479-481, 1996.
26. Hockenbery D., Nunez G., and Milliman C.: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336, 1990.
27. Hollstein M., Sidransky D., Vogelstein B., and Haris C.C.: p53 mutation in human cancers. Science 25, 49-53, 1991.
28. Holm R., Skomedal H., Helland A., Kristensen G., Borrensen A.L., and Nesland J.M.: Immunohistochemical analysis of p53 protein overexprcssion in normal premalignant and malignant tissue of the cervix uteri. J. Pathol. 169, 21-26, 1993.
29. Howell W.M., Denton T.E., and Diamond J.R.: Differential staining of the satellite regions of human acrocentric chromosomes. Experientia 31, 260-262, 1975.
30. Hughes R.G., Neill W.A., and Norvat M.: Nuclear DNA analysis of Koilocytic and pre-malignant lesions of the uterine cervix. Br. Med. J. 294, 267-269, 1987.
31. Isobe M., Emanuel B.S., Givol D., Oren M., and Croce C.M.: Localization of gene for human p53 tumour antigen to band 17p13. Nature 32, 84-85, 1986.
32. Jas Kulski D., DeRiel J. K., Mercer W.E., Calabretta B., and Baserga R.: Inhibition of cellular proliferation by antisense oligodeoxy nucleotides to PCNA/cyclin. Science 240, 1544-1546, 1988.
33. Jordan E.G.: Nucleolar nomenclature. J. Cell Sci. 67, 217-220, 1984.
34. Kaneko S., and Izutsu T.: Use of bromodeoxy uridrne, proliferating cell nuclear antigen, and nucleolar organizer regions in the multiparametric assessment of proliferating potency in cervical intraepithclial neoplasia. J. obstet. gynaecol 21, 133-144, 1995.
35. Kersemaekers A.M.F., Hermans J., Fleuren G.J., and Vijver M.J.: Loss of heterozygosity for defined regions on chromosome 3, 11 and 17 in carcinoma of the uterine cervix. Br. J. Cancer 77, 192-200, 1998.
36. Kobayashi I., Matsuo K., Ishibashi Y., Kanda S., and Sakai H.: The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analyzed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organizer region staining. Hum. Pathol. 25, 198-202, 1994.
37. Kurvinen K., Syrjanen K., and Syrjanen S.: p53 and bcl-2 proteins as prognostic markers in human papilloma virus-associated cervical lesions. J. Clin. Oncol. 14, 2120-2130, 1996.
38. Lahshmi S., Nair S.A., Jayasreek K., Jayaprakash P.G., Rajalekshmy T.N., Kannan S., and Pillai R.: Argyrophilic nucleolar organizer regions (AgNOR) in inflammatory premalignant and malignant lesions of the uterine cervix. Cancer Lett. 71, 197-201, 1993.
39. Lee C.S., and Gad J.: Nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Pathol. Int. 48, 806-811, 1998.
40. Liao S.Y., Brewer C., Zavada J., Pastorck J., Pastorekova S., Manetta A., Berman M.L., Disaia P. J., and Stanbridge E. J.: Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinoma. Am. J. Pathol. 745, 598-609, 1994.
41. Maddox P., Sasieni P., Szarewski A., Anolerson M., and Hanby A.: Differential expression of keratins 10, 17 and 19 in normal cervical epithelium, cervical intraepithelial neoplasia and cervical carcinoma. J. Clin. Pathol. 52, 41-46, 1999.
42. Mitra A.B., Murty V.V., Singh V., Li R.G., Pratap M., Sodhani P., Luthrau K., and Chaganti R.S.: Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix. J. Natl. Cancer Inst. 87, 742-745, 1995.
43. Mittal K.R., Demopoulos R. I., and Goswami S.: Proliferating cell nuclear antigen (cyclin) expression in normal and abnormal cervical squamous epithelia. Am. J. Surg. Pathol. 17, 117-122, 1993.
44. Muscare M., Giuffre G., Tuccari G., and Barresi G.: Nucleolar organizer regions in dysplastic and ncoplastic lesions of the large bowel. Eur. J. Histochem. 35, 401-408, 1991.
45. Nakagawa S., Yoshikawa H., Kimura M., Kawana K., Matsumoto K., Onda T., Kino N., Yamada M., Yasugi T., and Taketani Y.: A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix. Br. J. Cancer 79, 589-594. 1999.
46. Oka K., Nakano T., and Arai T.: P53 CM1 expression is not associated with prognosis in uterine cervical carcinoma. Cancer 72, 160-164, 1993.
47. Perticarari S., Presani G., Michelutti A., Facca M.C., Alberico S., and Mandruzzato G.P.: Flow cytometric analysis of DNA content in cervical lesions. Pathol. Res. Pract. 185, 686-688, 1989.
48. Raju G.C.: Expression of the proliferating cell nuclear antigen in cervical neoplasia. Int. J. Gynaecol. Pathol. 13, 337-341, 1994.
49. Reeves B.R., Casay G., Honeycombe J.R. and Smith S.: Correlation of differentiation state and silver staining of nucleolar organizers in the promyelocytic leukaemia cell line HL-60. Cancer Genet. Cytogenet. 13, 159-166, 1984.
50. Richart R.M., and Wilbanks G.D.: The chromosomes of human intraepitheliul neoplasia. Cancer Res. 26, 60-74, 1966.
51. Richart R.M.: Natural history of cervical intraepithelial neoplasia. Clin. Obstet. Gynaecol. 10, 748-784, 1967.
52. Saegusa M., Takano Y., Hashimura M., Shoji Y., and Okayasu I.: The possible role of bcl-2 expression in the progression of tumours of the uterine cervix. Cancer 76, 2297-2303, 1995.
53. Skopelitou A., Kamina S., Krikoni O., Alexopoulou V., and Agnantis N. J.: p53 Do-1 immunohistochenical overexpression in prcmalignant and malignant cervical lesions. Anticancer Res. 17, 269-276, 1997.
54. Slagle B.L., Kaufman R.H., Reeves W.C., and Icenogle J.P.: Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia. Cancer 83, 1401-1408, 1998.
55. Smedts F., Ramaekers F., Leube R.E., Link M.K. and Voujis P.: Expression of keratins 1, 6, 15, 16 and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma. Am. J. Pathol. 142, 403-412, 1993.
56. Steinbeck R.G., Heselmeyer K.M., Moberger H.B., and Aver G.U.: The relationship between proliferating cell nuclear antigen (PCNA), nuclear DNA content and mutant p53 during genesis of cervical carcinoma. Acta Oncol. 34, 171-176, 1995.
57. Steinbeck R.G.: Proliferation and DNA aneuploidy in mild dysplasia imply early steps of cervical carcinogenesis. Acta Oncol. 36, 3-12, 1997.
58. Talvensari A., Apaja-Sarkkinen M., Hoyhtya M., Westerlund A., Puistola U., and Turpeenniemi T.: Matrix metalloproteinase 2 immunoreative protein appears early in cervical epithelial dedifferentiation. Gynecol. Oncol. 72, 306-311, 1999.
59. Ter Harmsel B.T., Smedts P., Kuijpers J., Jeurink M., Trimbos B., and Ramaekers P.: bcl-2 immunoreactivity increases with severity of CIN, a study of normal cervical epithclia, CIN, and cervical carcinoma. J. Pathol. 179, 26-30, 1996.
60. Trere D., Parabegoli P., Cancellieri A., Ceccarelli C., Eusebi V., and Derenzini M.: AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining. J. Pathol. 165, 53-59, 1991.
61. Uchimura M., Kenjo T., Kuroshima Y., Fujii A., and Yamauchi S.: Immunohistochemical studies on a new antigen associated with squamous cell cancer in oncogenesis of uterine cervical cancer. Nippon Sanka Fujinka Gakkai Zasshi 43 (in Japanese), 73-79, 1991.
62. Werness B.A., Levine A.J., and Howley P.M.: Association of human papilloma virus type 16 and 18 E6 proteins with p53. Science 24, 76-79, 1990.
63. Wilbanks G.D., Terner J.Y., and Richart R.M.: The DNA content of cervical intraepithelial neoplasia studied by two-wave length Feulgen cytophotometry. Am. J. Obstet. Gynaecol. 98, 292, 1967.
64. Wong R.L., Katz M.E., Ogata K., Tan E.M., and Cohen S.: Inhibition of nuclear DNA synthesis by an auto-antibody to proliferating cell nuclear antigen /cyclin. Cell Immunol. 110, 443-448, 1987.
65. Yang L., Hashimura K., Qin C., Shrestha P., Sumitomo S., and Mori M.: Immunoreactivity of proliferating cell nuclear antigen in salivary gland tumours: an assessment of growth potential. Virchows Arch. 422, 481-486, 1993.
66. Yokoyama Y., Serdar D., Niwa K., and Tamaya T.: Nuclear organizer regions in malignant transformation of uterine cervix. Gynecol. Oncol. 39, 309-313, 1990.